CADL
CADL

Candel Therapeutics Inc

NASDAQ · Biotechnology
$5.83
+0.54 (+10.21%)
Analyst Consensus
Strong Buy
14 analysts
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +716.3% upside
Low Target $33.44
Average Target $47.59
High Target $47.92
Current Price $5.83
Current
$5.83
Target
$47.59
$33.44 $47.59 avg $47.92